BioSpace News Archive

PPD, Inc. (Nasdaq: PPD ), has been recognized as a top employer in Bulgaria, adding to the global contract research organization’s growing list of accolades as an employer of choice around the world. PPD was recognized as a top 50 desirable employer in Bulgaria, according to the second annual Employer of Choice Survey organized by the employer brand and business consulting agency To The Top. The organization sel

Brii Biosciences (“Brii Bio”), a multi-national company developing innovative therapies for diseases with significant unmet medical needs and large public health burden, announced today the appointments of Rogers Yongqing Luo, B.M., MBA, as President of the company and General Manager for greater China, and Ankang Li, Ph.D., J.D., CFA, as Chief Financial Officer of the company.

Magnolia Medical Technologies, Inc. today announced the appointment of two healthcare safety veterans to its Medical & Scientific Advisory Board (MSAB) – Richard (Rick) M. Ivey, retired Worldwide Vice President of Research & Development for Becton Dickinson (BD) Life Sciences

Siren, a technology company that has developed a breakthrough remote patient monitoring application using sensor-embedded fabrics, announced today the appointment of Andrei Marinescu as Chief Marketing Officer.

Augmented Reality (AR) is revolutionizing the medical imaging lens market.

Schweiger Dermatology Group, the fastest-growing dermatology practice in the Northeast, announced it has completed the acquisitions of Dr. Lillian Graf in Bayside, New York and Dr. Leopold Laufer in Brooklyn, New York.

Amytrx Therapeutics, Inc., (“Amytrx”), a clinical stage biopharmaceutical company advancing next-generation inflammation-targeting therapies, today launched from stealth to announce the company’s novel therapeutic platform, clinical development plans, and preclinical program initiatives.

Analyst and investor conference call and webcast scheduled for Tuesday, September 29, 2020 at 9:00 a.m. EDT / 3:00 p.m. CEST

Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of checkpoint antibodies, cell therapy, adjuvants, and vaccines designed to activate immune response to cancers and infections, today announced that Dr. Jennifer Buell, President and COO of Agenus, spoke to Jeremy Abbate, Publisher of Scientific American

Keeping our young people healthy and active amid coronavirus related closures is essential, and while organizations continue to scramble and pivot, the American Diabetes Association® has transformed Project Power virtually.